NDC 61958-2002

DESCOVY

Emtricitabine And Tenofovir Alafenamide

DESCOVY is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is Emtricitabine; Tenofovir Alafenamide Fumarate.

Product ID61958-2002_3280d94c-8145-478d-b718-91358fdca9de
NDC61958-2002
Product TypeHuman Prescription Drug
Proprietary NameDESCOVY
Generic NameEmtricitabine And Tenofovir Alafenamide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2016-04-04
Marketing CategoryNDA / NDA
Application NumberNDA208215
Labeler NameGilead Sciences, Inc.
Substance NameEMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
Active Ingredient Strength200 mg/1; mg/1
Pharm ClassesHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 61958-2002-1

30 TABLET in 1 BOTTLE, PLASTIC (61958-2002-1)
Marketing Start Date2016-04-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 61958-2002-2 [61958200202]

DESCOVY TABLET
Marketing CategoryNDA
Application NumberNDA208215
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2020-01-22

NDC 61958-2002-1 [61958200201]

DESCOVY TABLET
Marketing CategoryNDA
Application NumberNDA208215
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-04-04

Drug Details

Active Ingredients

IngredientStrength
EMTRICITABINE200 mg/1

OpenFDA Data

SPL SET ID:06f66e98-e6ee-4538-9506-6c1282cc14c1
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1747697
  • 1747691
  • UPC Code
  • 0361958200219
  • Pharmacological Class

    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

    Medicade Reported Pricing

    61958200201 DESCOVY 200-25 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "DESCOVY" or generic name "Emtricitabine And Tenofovir Alafenamide"

    NDCBrand NameGeneric Name
    61958-2002DESCOVYemtricitabine and tenofovir alafenamide
    61958-2005DESCOVYemtricitabine and tenofovir alafenamide
    70518-0230DESCOVYemtricitabine and tenofovir alafenamide fumarate

    Trademark Results [DESCOVY]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DESCOVY
    DESCOVY
    86170326 4876632 Live/Registered
    Gilead Sciences Ireland UC
    2014-01-20

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.